Arix Bioscience PLC (LON:ARIX)

Arix Bioscience PLC (LON:ARIX)


Share Price
133.50 p
Change
0 (0.00 %)
Market Cap
£180.96 m
Proactive Investors - Run By Investors For Investors

Arix Bioscience PLC RNS Release

Arix Bioscience Plc - Director/PDMR Shareholding


Arix Bioscience Plc - Director/PDMR Shareholding

PR Newswire

10 May 2019

ARIX BIOSCIENCE PLC

Director/PDMR Shareholding

Arix Bioscience plc today announces the annual award of nil cost options to certain members of management, all of which are subject to performance conditions over a three year assessment period, in accordance with the company’s Remuneration Policy.

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Joseph Anderson
2 Reason for the notification
a) Position / status Chief Executive Officer
b) Initial notification /
Amendment
Initial Notification
3 Details of issuer
a) Name Arix Bioscience plc
b) LEI 213800OVT3AHQCXNIX43
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of Arix Bioscience plc
Identification code GB00BD045071
b) Nature of the transaction Award of nil-cost options under the Arix Bioscience plc Executive Incentive Plan ("EIP") 
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 578,368
d) Aggregated information Aggregated price Aggregated volume
N/A (single transaction) N/A (single transaction)
e) Date of the transaction 09 May 2019
f) Place of the transaction Outside a trading venue

   

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name James Hedley Rawlingson
2 Reason for the notification
a) Position / status Chief Financial Officer
b) Initial notification /
Amendment
Initial Notification
3 Details of issuer
a) Name Arix Bioscience plc
b) LEI 213800OVT3AHQCXNIX43
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of Arix Bioscience plc
Identification code GB00BD045071
b) Nature of the transaction Award of nil-cost options under the Arix Bioscience plc Executive Incentive Plan ("EIP") 
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 234,239
d) Aggregated information Aggregated price Aggregated volume
N/A (single transaction) N/A (single transaction)
e) Date of the transaction 09 May 2019
f) Place of the transaction Outside a trading venue

   

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Robert Lyne
2 Reason for the notification
a) Position / status Chief Operating Officer
b) Initial notification /
Amendment
Initial Notification
3 Details of issuer
a) Name Arix Bioscience plc
b) LEI 213800OVT3AHQCXNIX43
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of Arix Bioscience plc
Identification code GB00BD045071
b) Nature of the transaction Award of nil-cost options under the Arix Bioscience plc Executive Incentive Plan ("EIP") 
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 195,199
d) Aggregated information Aggregated price Aggregated volume
N/A (single transaction) N/A (single transaction)
e) Date of the transaction 09 May 2019
f) Place of the transaction Outside a trading venue

For further information:

Robert Lyne                        Chief Operating Officer                +44 (0)207 290 1050

 - Ends -

Arix Bioscience PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use